The Efficacy of Self-MONitoring of blood glucose in patients with type two diabetes mellitus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN49814766

Enrollment

200

Registered

2007-02-26

Start date

2000-12-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type two diabetes mellitus Nutritional, Metabolic, Endocrine Non-insulin-dependent diabetes mellitus

Interventions

Self monitoring of blood glucose versus non-monitoring.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with newly diagnosed type two diabetes 2. Aged less than 70 years old

Exclusion criteria

Exclusion criteria: 1. Secondary diabetes 2. Insulin use 3. Previous monitoring 4. Pregnancy 5. Previous malignancy 6. Major illness within 6 months (including major surgery, myocardial infarction (MI), acute coronary syndrome, stroke, acute limb ischaemia) 7. Liver disease 8. Creatinine > 150 µmol/L 9. Proteinuria > 0.5 g/ 24 h 10. Chronic use of oral steroids 11. Alcohol abuse

Design outcomes

Primary

Measure	Time frame
1. Between-group differences in glycaemic control (HbA1c) 2. Between-group differences in psychological indices 3. Between-group differences in reported hypoglycaemia	—

Secondary

Measure	Time frame
1. Between-group differences in body mass index (BMI) 2. Between-group differences in oral hypoglycaemic drug usage 3. Longitudinal within-group changes in HbA1c, BMI and psychological indices	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026